
Sheba Medical Center becomes OpenAI's first international hospital partner. The deal mirrors banks' strategy: ground a general model in an institution's own rules.
Sheba Medical Center became OpenAI’s first international hospital partner Tuesday, giving physicians and researchers secure access to a clinical reasoning platform that cites peer-reviewed studies and guidelines. The more important part of the deal is what comes next: Sheba plans to feed its own clinical protocols and policy documents into the system, so the AI’s answers reflect how the hospital actually practices medicine.
“We are not just implementing AI in medicine but building a fully AI-powered hospital,” said Dr. Eyal Zimlichman, Sheba’s chief innovation officer. OpenAI’s models will not be trained on Sheba’s data, and patient information stays isolated under audit protocols, i24NEWS reported. Final medical decisions remain with clinicians. Sheba gets early access to OpenAI’s newest models for research.
The move follows a pattern that banks pioneered years ago. A generic AI model that ignored a bank’s lending policies or compliance rules risked violating regulations. So vendors started building directly into bank infrastructure instead of selling a standalone product. Anthropic launched 10 financial-services AI agents this year for underwriting reviews and know-your-customer checks, tools designed to plug into a bank’s existing risk systems, PYMNTS reported. Experian built an Agent Operating System inside its Ascend Platform to give lenders auditability and oversight across every stage of an AI agent’s lending decision, PYMNTS reported. In both cases, the value is not the underlying model but the layer that makes the model behave like that specific bank.
Hospitals face the same constraint. A general-purpose model reflects broad medical literature, not a hospital’s own treatment pathways. Cedars-Sinai made that gap explicit in May when it partnered with clinical AI platform OpenEvidence. The hospital plans to incorporate its own care pathways so clinicians see literature alongside Cedars-Sinai-specific guidance, Newswise reported. “Medicine is not practiced in the abstract. It is practiced on individual patients with unique histories and complexities,” OpenEvidence CEO Daniel Nadler said.
Mount Sinai took the same approach two months earlier, becoming OpenEvidence’s first enterprise health system deal. The seven-hospital network gave clinicians access to a platform pulling from clinical guidelines and peer-reviewed literature, Becker’s Hospital Review reported. “We are equipping every member of the care team with real-time access to rigorously sourced, evidence-based insights,” said Girish Nadkarni, Mount Sinai’s chief AI officer.
The underlying model is becoming commodity infrastructure. The proprietary rules layered on top are becoming the differentiator. Cedars-Sinai, Mount Sinai and now Sheba are each betting that a model trained on their own protocols will outperform a more capable model that isn’t.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.